780 related articles for article (PubMed ID: 32680511)
1. Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects.
Li C; Jiang P; Wei S; Xu X; Wang J
Mol Cancer; 2020 Jul; 19(1):116. PubMed ID: 32680511
[TBL] [Abstract][Full Text] [Related]
2. Expression of costimulatory and inhibitory receptors in FoxP3
Toker A; Ohashi PS
Adv Cancer Res; 2019; 144():193-261. PubMed ID: 31349899
[TBL] [Abstract][Full Text] [Related]
3. Metabolic profiles of regulatory T cells in the tumour microenvironment.
Rao D; Verburg F; Renner K; Peeper DS; Lacroix R; Blank CU
Cancer Immunol Immunother; 2021 Sep; 70(9):2417-2427. PubMed ID: 33576875
[TBL] [Abstract][Full Text] [Related]
4. FoxP3
Saleh R; Elkord E
Cancer Lett; 2020 Oct; 490():174-185. PubMed ID: 32721551
[TBL] [Abstract][Full Text] [Related]
5. Immunometabolic Checkpoints of Treg Dynamics: Adaptation to Microenvironmental Opportunities and Challenges.
Pacella I; Piconese S
Front Immunol; 2019; 10():1889. PubMed ID: 31507585
[TBL] [Abstract][Full Text] [Related]
6. Reprogramming the Tumor Microenvironment to Improve Immunotherapy: Emerging Strategies and Combination Therapies.
Datta M; Coussens LM; Nishikawa H; Hodi FS; Jain RK
Am Soc Clin Oncol Educ Book; 2019 Jan; 39():165-174. PubMed ID: 31099649
[TBL] [Abstract][Full Text] [Related]
7. Anti-regulatory T cells.
Andersen MH
Semin Immunopathol; 2017 Apr; 39(3):317-326. PubMed ID: 27677755
[TBL] [Abstract][Full Text] [Related]
8. Treg programming and therapeutic reprogramming in cancer.
Moreno Ayala MA; Li Z; DuPage M
Immunology; 2019 Jul; 157(3):198-209. PubMed ID: 30866047
[TBL] [Abstract][Full Text] [Related]
9. Regulatory T cells as therapeutic targets and mediators.
Sharma A; Rudra D
Int Rev Immunol; 2019; 38(5):183-203. PubMed ID: 31154878
[TBL] [Abstract][Full Text] [Related]
10. Remodeling of the tumor microenvironment via disrupting Blimp1
Dixon ML; Luo L; Ghosh S; Grimes JM; Leavenworth JD; Leavenworth JW
Mol Cancer; 2021 Nov; 20(1):150. PubMed ID: 34798898
[TBL] [Abstract][Full Text] [Related]
11. Regulatory T Cells: the Many Faces of Foxp3.
Georgiev P; Charbonnier LM; Chatila TA
J Clin Immunol; 2019 Oct; 39(7):623-640. PubMed ID: 31478130
[TBL] [Abstract][Full Text] [Related]
12. Regulatory T cells in cancer immunosuppression - implications for anticancer therapy.
Togashi Y; Shitara K; Nishikawa H
Nat Rev Clin Oncol; 2019 Jun; 16(6):356-371. PubMed ID: 30705439
[TBL] [Abstract][Full Text] [Related]
13. Regulatory circuits of T cell function in cancer.
Speiser DE; Ho PC; Verdeil G
Nat Rev Immunol; 2016 Oct; 16(10):599-611. PubMed ID: 27526640
[TBL] [Abstract][Full Text] [Related]
14. The function and potential drug targets of tumour-associated Tregs for cancer immunotherapy.
Yan S; Zhang Y; Sun B
Sci China Life Sci; 2019 Feb; 62(2):179-186. PubMed ID: 30610537
[TBL] [Abstract][Full Text] [Related]
15. Tumor microenvironment dictates regulatory T cell phenotype: Upregulated immune checkpoints reinforce suppressive function.
Kim HR; Park HJ; Son J; Lee JG; Chung KY; Cho NH; Shim HS; Park S; Kim G; In Yoon H; Kim HG; Jung YW; Cho BC; Park SY; Rha SY; Ha SJ
J Immunother Cancer; 2019 Dec; 7(1):339. PubMed ID: 31801611
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic alterations, clinical impact and therapeutic potential of regulatory T cells in cancer.
Chaudhary B; Abd Al Samid M; al-Ramadi BK; Elkord E
Expert Opin Biol Ther; 2014 Jul; 14(7):931-45. PubMed ID: 24661020
[TBL] [Abstract][Full Text] [Related]
17. Challenges and future perspectives of T cell immunotherapy in cancer.
de Aquino MT; Malhotra A; Mishra MK; Shanker A
Immunol Lett; 2015 Aug; 166(2):117-33. PubMed ID: 26096822
[TBL] [Abstract][Full Text] [Related]
18. Regulatory T-Cell Therapy in Liver Transplantation and Chronic Liver Disease.
Hann A; Oo YH; Perera MTPR
Front Immunol; 2021; 12():719954. PubMed ID: 34721383
[TBL] [Abstract][Full Text] [Related]
19. Regulatory T cells and their roles in immune dysregulation and allergy.
Pellerin L; Jenks JA; Bégin P; Bacchetta R; Nadeau KC
Immunol Res; 2014 May; 58(2-3):358-68. PubMed ID: 24781194
[TBL] [Abstract][Full Text] [Related]
20. Re-education of the Tumor Microenvironment With Targeted Therapies and Immunotherapies.
Ngiow SF; Young A
Front Immunol; 2020; 11():1633. PubMed ID: 32849557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]